Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Pharmacological Inhibition of miR-126 Enhances Venetoclax Activity in Acute Myeloid Leukemia

Blood blood.2025029875.

https://doi.org/10.1182/blood.2025029875

Published: 2025

Includes: Supplemental data

Journal Articles

ST2 promotes leukemia transformation by reshaping the immune landscape in Acute Myeloid Leukemia

Yu-Hsuan Fu, Man Li, Ying-Chieh Chen, Lianjun Zhang, Wancheng Guo, David Frankhouser, Denis O'Meally, Jihyun Irizarry, Jennifer Rangel Ambriz, Ziang Chen, Bin Zhang, Sergio Branciamore, Guido Marcucci, Russell Rockne, Ya-Huei Kuo

Blood (2025) 146 (Supplement 1): 1459.

https://doi.org/10.1182/blood-2025-1459

Published: 2025

Journal Articles

Targeting adss overcomes venetoclax resistance in TP53-mutated acute myeloid leukemia

Blood (2025) 146 (Supplement 1): 213.

https://doi.org/10.1182/blood-2025-213

Published: 2025

Journal Articles

New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein

Yaonan Hong, Shiyue Wu, Shun He, Qi Liu, Yingying Shen, Xiawan Yang, Peicheng Wang, Baodong Ye, Keding Shao, Ya-Huei Kuo, Dijiong Wu

Blood (2025) 146 (Supplement 1): 1695.

https://doi.org/10.1182/blood-2025-1695

Published: 2025

Journal Articles

Chronic myeloid leukemia (CML) evolution is not encoded in single-cell microstates, but emerges from population-level macrostates

David Frankhouser, Dandan Zhao, Yu-Hsuan Fu, Anupam Dey, Ziang Chen, Jihyun Irizarry, Jennifer Rangel Ambriz, Sergio Branciamore, Denis O'Meally, Jeffrey Trent, Stephen Forman, Ya-Huei Kuo, Adam MacLean, Bin Zhang, Russell Rockne, Guido Marcucci

Blood (2025) 146 (Supplement 1): 5026.

https://doi.org/10.1182/blood-2025-5026

Published: 2025

Journal Articles

Immune Dysregulation and State-Transition Transcriptomic Signatures Underlying Pediatric Chronic Myeloid Leukemia Pathogenesis

Tiffany Ybarra, David Frankhouser, Ryan Sathianathen, Minyoung Youn, Ramesh Nair, Ya-Huei Kuo, Guido Marcucci, Russell Rockne, Kathleen Sakamoto

Blood (2025) 146 (Supplement 1): 1982.

https://doi.org/10.1182/blood-2025-1982

Published: 2025

Journal Articles

From theory to therapy: Predicting response to chemotherapy with multiomic longitudinal profiling of peripheral blood in AML

Jennifer Rangel Ambriz, Ziang Chen, Yu-Hsuan Fu, David Frankhouser, Denis O'Meally, Sergio Branciamore, Jihyun Irizarry, Bin Zhang, Lianjun Zhang, Ying-Chieh Chen, Guido Marcucci, Russell Rockne, Ya-Huei Kuo

Blood (2025) 146 (Supplement 1): 5284.

https://doi.org/10.1182/blood-2025-5284

Published: 2025

Journal Articles

High HDAC8 Creates Targetable Vulnerabilities in Acute Myeloid Leukemia through Dysregulation of BRCA1-Related RNA Splicing Machinery and Defective DNA Damage Repair

Lianjun Zhang, Yu-Hsuan Fu, Wei-Kai Hua, Le Xuan Truong Nguyen, Xin He, Wancheng Guo, Yinghui Zhu, Ying-Chieh Chen, Zhenhua Chen, Haojie Dong, Lei Zhang, Bin Zhang, Jeremy Stark, Ling Li, Guido Marcucci, Ya-Huei Kuo

Blood (2024) 144 (Supplement 1): 1398.

https://doi.org/10.1182/blood-2024-208137

Published: 2024

Journal Articles

Free Energy Changes at State-Transition Critical Points As a Patient-Specific Biomarker in Acute Myeloid Leukemia

Lisa Uechi, Swetha Vasudevan, Daniella Vilencki, Sergio Branciamore, David Frankhouser, Denis O'Meally, Soheil Meshinchi, Guido Marcucci, Ya-Huei Kuo, Nataly Kravchenko-Balasha, Russell C. Rockne

Blood (2023) 142 (Supplement 1): 6012.

https://doi.org/10.1182/blood-2023-190662

Published: 2023

Journal Articles

Acquired microRNA-142 Deficit Drives Escape Mechanisms of Anti-Leukemic Surveillance during Blast Crisis Transformation of Chronic Myeloid Leukemia (CML)

Blood (2023) 142 (Supplement 1): 3152.

https://doi.org/10.1182/blood-2023-182587

Published: 2023

Journal Articles

Single-Cell RNA-Seq Reveals Intermediate Cell States and Identifies Features Defining Cellular Heterogeneity in Inv(16) Acute Myeloid Leukemia (AML)

Yu-Hsuan Fu, Lianjun Zhang, Ying-Chieh Chen, David Frankhouser, Lisa Uechi, Denis O'Meally, Sergio Branciamore, Guido Marcucci, Russell C. Rockne, Ya-Huei Kuo

Blood (2023) 142 (Supplement 1): 5683.

https://doi.org/10.1182/blood-2023-182484

Published: 2023

Journal Articles

Dysregulated Alternative Splicing in Inv(16) Acute Myeloid Leukemia Via U2AF1 Deacetylation during DNA Damage Response

Lianjun Zhang, Yu-Hsuan Fu, Wei-Kai Hua, Le Xuan Truong Nguyen, Yinghui Zhu, Ying-Chieh Chen, Xin He, Man Li, Haojie Dong, Bin Zhang, Ling Li, Jeremy Stark, Guido Marcucci, Ya-Huei Kuo

Blood (2023) 142 (Supplement 1): 5700.

https://doi.org/10.1182/blood-2023-182215

Published: 2023

Journal Articles

Synergistic Activity of Adefovir Dipivoxil and Venetoclax to Target the Bioenergetic Metabolism of Acute Myeloid Leukemia

Xubo Gong, Yi Zhang, Ying-Chieh Chen, Dandan Zhao, Yongfang Xu, Xin He, Fang Chen, Lei Zhang, Lianjun Zhang, Katrina Estrella, Melissa Valerio, Lucy Y. Ghoda, Le Xuan Truong Nguyen, Ya-Huei Kuo, Weiwei Liu, Zhihua Tao, Guido Marcucci, Bin Zhang

Blood (2023) 142 (Supplement 1): 4161.

https://doi.org/10.1182/blood-2023-187183

Published: 2023

Journal Articles

Uncovering the Transcriptional Landscape of CML Development and Therapeutic Interventions Via State-Transition Modeling

David Frankhouser, Dandan Zhao, Russell C. Rockne, Sergio Branciamore, Lisa Uechi, Denis O'Meally, Ya-Huei Kuo, Bin Zhang, Guido Marcucci

Blood (2023) 142 (Supplement 1): 3154.

https://doi.org/10.1182/blood-2023-188645

Published: 2023

Journal Articles

In Vivo Antileukemic Activity of Ost-01 in Acute Myeloid Leukemia (AML): A Novel Natural Product (NP) from Baccharis Coridifolia

Hyunjun Kang, Dinh Hoa Hoang, Melissa Valerio, Khyatiben V. Pathak, Lianjun Zhang, Ralf Buettner, Fang Chen, Katrina Estrella, William Graff, Ya-Huei Kuo, Bin Zhang, Patrick Pirrotte, Le Xuan Truong Nguyen, Guido Marcucci

Blood (2023) 142 (Supplement 1): 1565.

https://doi.org/10.1182/blood-2023-187736

Published: 2023

Journal Articles

Application of State Transition Theory and Treatment Modeling for Predicting Response to Chemotherapy in a Mouse Model of Acute Myeloid Leukemia

Lisa Uechi, Yu-Hsuan Fu, David Frankhouser, Denis O'Meally, Sergio Branciamore, Lianjun Zhang, Man Li, Guido Marcucci, Russell C. Rockne, Ya-Huei Kuo

Blood (2023) 142 (Supplement 1): 2961.

https://doi.org/10.1182/blood-2023-190603

Published: 2023

Journal Articles

Exploiting the Metabolic Vulnerability of Leukemic Stem Cells (LSCs) in Inv(16) Acute Myeloid Leukemia (AML) with the Combination of Miristen, a Mir-126 Inhibitor, and Venetoclax

Lianjun Zhang, Dinh Hoa Hoang, Hyunjun Kang, Ying-Chieh Chen, Yu-Hsuan Fu, Khyatiben V. Pathak, Melissa Valerio, Fang Chen, Katrina Estrella, Ralf Buettner, Bin Zhang, Patrick Pirrotte, Guido Marcucci, Ya-Huei Kuo, Le Xuan Truong Nguyen

Blood (2023) 142 (Supplement 1): 2953.

https://doi.org/10.1182/blood-2023-186936

Published: 2023

Journal Articles

CD84 Is a Therapeutically Targetable Driver of Leukemogenesis Via Disruption of Energy Supply in Acute Myeloid Leukemia

Yinghui Zhu, Miso Park, Mariam Murtadha, Enrico Caserta, Le Xuan Truong Nguyen, Mahmoud Singer, Marc Denisse Estepa, Lokesh Nigam, Ada Alice Dona', James F Sanchez, Theophilus Tandoh, Man Li, Bin Zhang, Ya-Huei Kuo, Guido Marcucci, John C Williams, Flavia Pichiorri

Blood (2022) 140 (Supplement 1): 89–90.

https://doi.org/10.1182/blood-2022-170300

Published: 2022

Journal Articles

HDAC8 Disrupts DNA Damage Response By Deacetylation of U2AF1 in Inv(16) Acute Myeloid Leukemia

Lianjun Zhang, Le Xuan Truong Nguyen, Wei-Kai Hua, Yinghui Zhu, Ying-Chieh Chen, Xin He, Man Li, Yu-Hsuan Fu, Haojie Dong, Bin Zhang, Ling Li, Jeremy Stark, Guido Marcucci, Ya-Huei Kuo

Blood (2022) 140 (Supplement 1): 8692–8693.

https://doi.org/10.1182/blood-2022-160280

Published: 2022

Journal Articles

Targeting PRMT9 Elicits Cgas-Mediated Anti-Leukemia Immunity

Blood (2022) 140 (Supplement 1): 4931–4933.

https://doi.org/10.1182/blood-2022-167366

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Pharmacological Inhibition of miR-126 Enhances Venetoclax Activity in Acute Myeloid Leukemia

ST2 promotes leukemia transformation by reshaping the immune landscape in Acute Myeloid Leukemia

Targeting adss overcomes venetoclax resistance in TP53-mutated acute myeloid leukemia

New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein

Chronic myeloid leukemia (CML) evolution is not encoded in single-cell microstates, but emerges from population-level macrostates

Immune Dysregulation and State-Transition Transcriptomic Signatures Underlying Pediatric Chronic Myeloid Leukemia Pathogenesis

From theory to therapy: Predicting response to chemotherapy with multiomic longitudinal profiling of peripheral blood in AML

High HDAC8 Creates Targetable Vulnerabilities in Acute Myeloid Leukemia through Dysregulation of BRCA1-Related RNA Splicing Machinery and Defective DNA Damage Repair

Free Energy Changes at State-Transition Critical Points As a Patient-Specific Biomarker in Acute Myeloid Leukemia

Acquired microRNA-142 Deficit Drives Escape Mechanisms of Anti-Leukemic Surveillance during Blast Crisis Transformation of Chronic Myeloid Leukemia (CML)

Single-Cell RNA-Seq Reveals Intermediate Cell States and Identifies Features Defining Cellular Heterogeneity in Inv(16) Acute Myeloid Leukemia (AML)

Dysregulated Alternative Splicing in Inv(16) Acute Myeloid Leukemia Via U2AF1 Deacetylation during DNA Damage Response

Synergistic Activity of Adefovir Dipivoxil and Venetoclax to Target the Bioenergetic Metabolism of Acute Myeloid Leukemia

Uncovering the Transcriptional Landscape of CML Development and Therapeutic Interventions Via State-Transition Modeling

In Vivo Antileukemic Activity of Ost-01 in Acute Myeloid Leukemia (AML): A Novel Natural Product (NP) from Baccharis Coridifolia

Application of State Transition Theory and Treatment Modeling for Predicting Response to Chemotherapy in a Mouse Model of Acute Myeloid Leukemia

Exploiting the Metabolic Vulnerability of Leukemic Stem Cells (LSCs) in Inv(16) Acute Myeloid Leukemia (AML) with the Combination of Miristen, a Mir-126 Inhibitor, and Venetoclax

CD84 Is a Therapeutically Targetable Driver of Leukemogenesis Via Disruption of Energy Supply in Acute Myeloid Leukemia

HDAC8 Disrupts DNA Damage Response By Deacetylation of U2AF1 in Inv(16) Acute Myeloid Leukemia

Targeting PRMT9 Elicits Cgas-Mediated Anti-Leukemia Immunity

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only